CME Group Inc. (NASDAQ:CME) Shares Sold by HM Payson & Co.

HM Payson & Co. reduced its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 6.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 901 shares of the financial services provider’s stock after selling 61 shares during the period. HM Payson & Co.’s holdings in CME Group were worth $209,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in CME. SJS Investment Consulting Inc. grew its stake in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after buying an additional 97 shares during the last quarter. Truvestments Capital LLC bought a new position in CME Group during the 3rd quarter worth $26,000. Dunhill Financial LLC grew its stake in CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after buying an additional 81 shares during the last quarter. Financial Life Planners bought a new position in CME Group during the 4th quarter worth $32,000. Finally, Fortitude Family Office LLC grew its stake in CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after buying an additional 83 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently commented on CME. Barclays upped their price objective on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Oppenheimer increased their price target on CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Morgan Stanley increased their price target on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 19th. Deutsche Bank Aktiengesellschaft decreased their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Finally, Keefe, Bruyette & Woods increased their price target on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research note on Friday, February 14th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average price target of $235.50.

Read Our Latest Stock Report on CME

CME Group Trading Up 0.2 %

Shares of CME Group stock opened at $254.57 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The firm has a market cap of $91.74 billion, a price-to-earnings ratio of 26.33, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. The business has a fifty day simple moving average of $240.07 and a 200-day simple moving average of $230.85. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $258.78.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.96%. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio is currently 51.71%.

CME Group announced that its Board of Directors has approved a stock repurchase plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s leadership believes its stock is undervalued.

Insider Activity

In other news, insider Hilda Harris Piell sold 3,984 shares of the company’s stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the completion of the sale, the insider now directly owns 27,046 shares of the company’s stock, valued at $6,774,211.62. This represents a 12.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 17,076 shares of company stock valued at $4,271,496 over the last three months. Insiders own 0.30% of the company’s stock.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.